Clinical-epidemiological characterization of patients with long COVID in Mexico

Luis Del Carpio-Orantes1, Daniela Trelles-Hernández1, Sergio García-Méndez1

  • 1Grupo de Estudio para el Diagnóstico y Tratamiento de COVID-19 en Veracruz, México.

Gaceta Medica De Mexico
|August 8, 2024
PubMed
Abstract

Insights

Long COVID, characterized by persistent symptoms post-infection, affects millions globally. This study characterizes the Mexican population with long COVID, identifying key demographics and risk factors to inform future protocols.

Area of Science:

  • Medical Research
  • Public Health

Background:

  • Long COVID is defined as persistent symptoms four weeks after acute COVID-19 infection.
  • An estimated 65 to 200 million individuals worldwide are affected by long COVID.

Purpose of the Study:

  • To characterize the population affected by long COVID in Mexico.

Main Methods:

  • An online survey was administered to individuals over 18 years old meeting long COVID criteria.
  • Data from 203 participants were analyzed.

Main Results:

  • The study included 203 subjects, with 68% being female and an average age of 41.8 years.
  • Key risk factors identified were diabetes, overweight/obesity, and hypertension.
  • Fatigue and neuropsychiatric symptoms were the most commonly reported issues, with 89.7% having prior COVID-19 vaccination.

Conclusions:

  • Characterizing the long COVID population in Mexico is crucial.
  • This characterization will aid in developing diagnostic and treatment protocols for long COVID.

Related Concept Videos